A Tyrosine Kinase Inhibitor-Based High-Affinity PET Radiopharmaceutical Targets Vascular Endothelial Growth Factor Receptor

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

High Affinity ◽

Pet Radiopharmaceutical ◽

Everolimus zur Behandlung des metastasierten Nierenzellkarzinoms nach Versagen der ersten VEGFr-TKI(Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor)-Therapie: Ergebnisse einer Interimsanalyse einer nichtinterventionellen Studie

Karger Kompass Onkologie ◽

10.1159/000356898 ◽

2014 ◽

Vol 1 (1) ◽

pp. 28-29

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis

Cancer Research ◽

10.1158/0008-5472.can-07-5809 ◽

2008 ◽

Vol 68 (12) ◽

pp. 4754-4762 ◽

Cited By ~ 86

Author(s):

Caroline A. Heckman ◽

Tanja Holopainen ◽

Maria Wirzenius ◽

Salla Keskitalo ◽

Michael Jeltsch ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo

NMR in Biomedicine ◽

10.1002/nbm.961 ◽

2005 ◽

Vol 18 (5) ◽

pp. 308-321 ◽

Cited By ~ 44

Author(s):

Markus Rudin ◽

Paul M. J. McSheehy ◽

Peter R. Allegrini ◽

Martin Rausch ◽

Diana Baumann ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Contrast Agent ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

American Journal Of Pathology ◽

10.2353/ajpath.2008.071074 ◽

2008 ◽

Vol 173 (1) ◽

pp. 265-277 ◽

Cited By ~ 59

Author(s):

Cornelia Halin ◽

Hermann Fahrngruber ◽

Josef G. Meingassner ◽

Guido Bold ◽

Amanda Littlewood-Evans ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Skin Inflammation ◽

Vascular Endothelial ◽

AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer

Cancer Research ◽

10.1158/0008-5472.can-04-4409 ◽

2005 ◽

Vol 65 (10) ◽

pp. 4389-4400 ◽

Cited By ~ 542

Author(s):

Stephen R. Wedge ◽

Jane Kendrew ◽

Laurent F. Hennequin ◽

Paula J. Valentine ◽

Simon T. Barry ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Orally Bioavailable ◽

SU-011248, a vascular endothelial growth factor receptor-tyrosine kinase inhibitor, controls chronic psoriasis

Translational Research ◽

10.1016/j.trsl.2007.01.003 ◽

2007 ◽

Vol 149 (3) ◽

pp. 103-106 ◽

Cited By ~ 14

Author(s):

Mani Keshtgarpour ◽

Arkadiusz Z. Dudek

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR [KDR]-TKI), in a model of ZD1839 (‘Iressa’) resistance

European Journal of Cancer ◽

10.1016/s0959-8049(02)80842-5 ◽

2002 ◽

Vol 38 ◽

pp. S60-S61

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity

The Journal of Dermatology ◽

10.1111/j.1346-8138.2007.00304.x ◽

2007 ◽

Vol 34 (7) ◽

pp. 419-429 ◽

Cited By ~ 4

Author(s):

Aisaku YAMAMOTO ◽

Hideaki WATANABE ◽

Hirohiko SUEKI ◽

Takako NAKANISHI ◽

Hajime YASUHARA ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Contact Hypersensitivity ◽

Vascular Endothelial ◽

596 The Effect of Rifampin On the Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor

European Journal of Cancer ◽

10.1016/s0959-8049(12)72393-6 ◽

2012 ◽

Vol 48 ◽

pp. 183 ◽

Cited By ~ 2

Author(s):

M. Cotreau ◽

D. Subic ◽

L. Massmanian ◽

A. Strahs ◽

D. Vargo

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Vegfr Tyrosine Kinase Inhibitor

595 Effect of Ketoconazole On Pharmacokinetics of Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor

European Journal of Cancer ◽

10.1016/s0959-8049(12)72392-4 ◽

2012 ◽

Vol 48 ◽

pp. 182-183 ◽

Cited By ~ 1

Author(s):

M. Cotreau ◽

N. Siebers ◽

L. Massmanian ◽

A. Strahs ◽

D. Vargo

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽